SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets
Combinatorial therapies have been recently proposed to improve the efficacy of anticancer treatment. The SynergyFinder R package is a software used to analyze pre-clinical drug combination datasets. Here, we report the major updates to the SynergyFinder R package for improved interpretation and anno...
Main Authors: | Shuyu Zheng, Wenyu Wang, Jehad Aldahdooh, Alina Malyutina, Tolou Shadbahr, Ziaurrehman Tanoli, Alberto Pessia, Jing Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Genomics, Proteomics & Bioinformatics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1672022922000080 |
Similar Items
-
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
by: Tian Xia, et al.
Published: (2023-04-01) -
Mind the Curve: Dose–Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies
by: Olga Fuentealba-Manosalva, et al.
Published: (2023-06-01) -
Dynamical Synergy of Drug Combinations during Cancer Chemotherapy
by: Paolo Castorina, et al.
Published: (2022-11-01) -
Synergy Assessment of Four Antimicrobial Bioactive Compounds for the Combinational Treatment of Bacterial Pathogens
by: Kevin Masterson, et al.
Published: (2023-08-01) -
Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in Saccharomyces cerevisiae
by: Hamid Gaikani, et al.
Published: (2021-07-01)